Comparative analysis of persistence and remission with guselkumab versus secukinumab and ixekizumab in the United States
Purpose: Real-world data comparing long-term performance of interleukin (IL)-23 and IL-17 inhibitors in psoriasis are limited. This study compared treatment persistence and remission among patients initiating guselkumab versus IL-17 inhibitors.Methods: Adults with psoriasis initiating guselkumab, se...
Guardat en:
| Autors principals: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis Group
2024-12-01
|
| Col·lecció: | Journal of Dermatological Treatment |
| Matèries: | |
| Accés en línia: | https://www.tandfonline.com/doi/10.1080/09546634.2024.2349658 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|